Biomea Fusion Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
BMEA$0.60+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Cash flows from operating activities | |||
| Net loss | $(117,255) | $(81,828) | $(41,567) |
| Adjustments to reconcile net loss to net cash used in operating activities | |||
| Depreciation expense | 1,515 | 691 | 249 |
| Non-cash operating lease expense | 2,686 | 571 | 704 |
| Stock-based compensation expense | 14,131 | 10,336 | 6,234 |
| Net amortization of premiums and accretion of discounts on investments | 1 | 144 | 516 |
| Changes in operating assets and liabilities: | |||
| Prepaid expenses and other current assets | 2,478 | (1,725) | (2,517) |
| Other assets | (2,358) | (1,915) | (1,218) |
| Accounts payable | 2,562 | 2,960 | 640 |
| Accrued expenses and other current liabilities | 1,886 | 8,914 | 2,110 |
| Operating lease liabilities | (2,238) | (565) | (589) |
| Net cash used in operating activities | (96,592) | (62,417) | (35,438) |
| Cash flows from investing activities | |||
| Purchase of property and equipment | (3,370) | (1,030) | (3,171) |
| Purchase of investments | — | — | (38,492) |
| Maturities of investments | 1,150 | 28,371 | 8,308 |
| Net cash (used in) provided by investing activities | (2,220) | 27,341 | (33,355) |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock, net of issuance costs | 161,803 | — | — |
| Proceeds from issuance of common stock from initial public offering, net of issuance costs | — | — | 152,753 |
| Proceeds from exercise of stock options and purchases under the employee stock purchase plan | 1,995 | 1,239 | 468 |
| Payment from Paycheck Protection Program loan | — | — | (36) |
| Net cash provided by financing activities | 163,798 | 1,239 | 153,185 |
| Net increase (net decrease) in cash, cash equivalents, and restricted cash | 64,986 | (33,837) | 84,392 |
| Cash, cash equivalents, and restricted cash at the beginning of the period | 112,250 | 146,087 | 61,695 |
| Cash, cash equivalents, and restricted cash at the end of the period | $177,236 | $112,250 | $146,087 |
| Non-cash financing and investing activities: | |||
| Acquisition of operating lease right-of-use assets | $5,971 | $— | $3,216 |
| Acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities | $— | $2,537 | $— |
| Remeasurement of operating lease right-of-use assets and lease liability | $5,668 | — | — |
| Reconciliation of cash, cash equivalents, and restricted cash: | |||
| Cash and cash equivalents | $176,866 | $111,899 | $145,736 |
| Restricted cash | 370 | 351 | 351 |
| Total cash, cash equivalents, and restricted cash | $177,236 | $112,250 | $146,087 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.